Peptide services/genscript/mona EL gamil

Ended Awarded Last action

Contract number
HHSN26100042
Awardee
Awarding agency
Obligated
$5,311

Award facts

Opportunity
Contract value 100% obligated
$5,311.02 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Piscataway, NJ 08854, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 -$75
Other Administrative Action 1 $75
Original award $5,311

About this award

The National Cancer Institute issued a $5,311.02 delivery order to Genscript USA Inc. on November 3, 2015, for peptide services. Place of performance is Piscataway, New Jersey. The order has a firm fixed price and an ultimate completion date of December 3, 2015.

Quick answers

Who was awarded contract HHSN26100042?

HHSN26100042 was awarded to Genscript USA Inc. by National Cancer Institute (National Institutes of Health) on November 3, 2015.

How much is contract HHSN26100042 worth?

The government has obligated $5,311 on HHSN26100042.

Is contract HHSN26100042 an order under another contract?

Yes. HHSN26100042 is a delivery order under HHSN261201500015I, an indefinite delivery contract.

Was contract HHSN26100042 competed?

The extent of competition for HHSN26100042 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award